Journal of the American Society of Nephrology, Vol 8, 1921-1929, Copyright © 1997 by American Society of Nephrology

REGULAR ARTICLES

Anemia in hemodialysis patients: variables affecting this outcome predictor

F Madore, EG Lowrie, C Brugnara, NL Lew, JM Lazarus, K Bridges and WF Owen
Centre de Recherche, Hopital du Sacre-Coeur, Universite de Montreal, Quebec, Canada.

Despite the prevalent use of recombinant human erythropoietin (rhEPO), anemia is a frequent finding in hemodialysis patients. The goal of this study was to evaluate the impact of anemia on patient survival and characterize the determinants of hematopoiesis that may be amenable to therapeutic manipulation to enhance rhEPO responsiveness and reduce death risk. Patient characteristics and laboratory data were collected for 21,899 patients receiving hemodialysis three times per week in dialysis centers throughout the United States in 1993. Hemoglobin concentrations (Hb) < or =80 g/L were associated with a twofold increase in the odds of death (odds ratio = 2.01; P = 0.001) when compared with Hb 100 to 110 g/L. No improvement in the odds of death was afforded for Hb >110 g/L. Using multiple linear regression, variables of rhEPO administration (rhEPO dose and percentage of treatments that rhEPO was administered), variables of iron status (serum iron, transferrin saturation, and ferritin), variables of nutritional status (serum albumin and creatinine concentration), and the dose of dialysis (urea reduction ratio) were found to be significantly associated with hemoglobin concentration (P < 0.001). Age, race, and gender were also found to be significantly associated with hemoglobin concentrations (P < 0.001). From this report, the following conclusions may be made. (1) Anemia may be predictive of an increased risk of mortality in some hemodialysis patients. (2) Hemoglobin concentrations > 110 g/L are not associated with further improvements in the odds of death. (3) Laboratory surrogates of iron stores, nutritional status, and the delivered dose of dialysis are predictive of hemoglobin concentration. Whether manipulation of the factors that improve anemia will also enhance the survival of patients on hemodialysis is unknown and should be evaluated by prospective, interventional studies.

This article has been cited by other articles:

				Y. Zhang, M. Thamer, D. Cotter, J. Kaufman, and M. A. Hernan Estimated Effect of Epoetin Dosage on Survival among Elderly Hemodialysis Patients in the United States Clin. J. Am. Soc. Nephrol., March 1, 2009; 4(3): 638 - 644. [Abstract] [Full Text] [PDF]

				A. Ishani, C. A. Solid, E. D. Weinhandl, D. T. Gilbertson, R. N. Foley, and A. J. Collins Association between number of months below K/DOQI haemoglobin target and risk of hospitalization and death Nephrol. Dial. Transplant., May 1, 2008; 23(5): 1682 - 1689. [Abstract] [Full Text] [PDF]

				S. Amaral, W. Hwang, B. Fivush, A. Neu, D. Frankenfield, and S. Furth Serum Albumin Level and Risk for Mortality and Hospitalization in Adolescents on Hemodialysis Clin. J. Am. Soc. Nephrol., May 1, 2008; 3(3): 759 - 767. [Abstract] [Full Text] [PDF]

				D. T. Gilbertson, J. P. Ebben, R. N. Foley, E. D. Weinhandl, B. D. Bradbury, and A. J. Collins Hemoglobin Level Variability: Associations with Mortality Clin. J. Am. Soc. Nephrol., January 1, 2008; 3(1): 133 - 138. [Abstract] [Full Text] [PDF]

				E. Fong, J. M. Bargman, and C. T. Chan Cross-Sectional Comparison of Quality of Life and Illness Intrusiveness in Patients Who Are Treated with Nocturnal Home Hemodialysis versus Peritoneal Dialysis Clin. J. Am. Soc. Nephrol., November 1, 2007; 2(6): 1195 - 1200. [Abstract] [Full Text] [PDF]

				A. Ishani, H. Guo, D. T. Gilbertson, J. Liu, S. Dunning, A. J. Collins, and R. N. Foley Time to target haemoglobin concentration (11 g/dl) risk of hospitalization and mortality among incident dialysis patients Nephrol. Dial. Transplant., August 1, 2007; 22(8): 2247 - 2255. [Abstract] [Full Text] [PDF]

				W. Sulowicz, F. Locatelli, J.-P. Ryckelynck, J. Balla, B. Csiky, K. Harris, P. Ehrhard, U. Beyer, and on behalf of the PROTOS Study Investigators Once-Monthly Subcutaneous C.E.R.A. Maintains Stable Hemoglobin Control in Patients with Chronic Kidney Disease on Dialysis and Converted Directly from Epoetin One to Three Times Weekly Clin. J. Am. Soc. Nephrol., July 1, 2007; 2(4): 637 - 646. [Abstract] [Full Text] [PDF]

				P. Barany and H.-J. Muller Maintaining control over haemoglobin levels: optimizing the management of anaemia in chronic kidney disease Nephrol. Dial. Transplant., June 1, 2007; 22(suppl_4): iv10 - iv18. [Abstract] [Full Text] [PDF]

				S. D. Roger and A. Levin Epoetin trials: randomised controlled trials don't always mimic observational data Nephrol. Dial. Transplant., March 1, 2007; 22(3): 684 - 686. [Full Text] [PDF]

				J. C. Fink, V. D. Hsu, M. Zhan, L. D. Walker, C. D. Mullins, C. Jones-Burton, P. Langenberg, and S. L. Seliger Center Effects in Anemia Management of Dialysis Patients J. Am. Soc. Nephrol., February 1, 2007; 18(2): 646 - 653. [Abstract] [Full Text] [PDF]

				F. Locatelli, L. Del Vecchio, and P. Pozzoni Anemia and Cardiovascular Risk: The Lesson of the CREATE Trial J. Am. Soc. Nephrol., December 1, 2006; 17(12_suppl_3): S262 - S266. [Abstract] [Full Text] [PDF]

				T. B. Drueke, F. Locatelli, N. Clyne, K.-U. Eckardt, I. C. Macdougall, D. Tsakiris, H.-U. Burger, A. Scherhag, and the CREATE Investigators Normalization of Hemoglobin Level in Patients with Chronic Kidney Disease and Anemia N. Engl. J. Med., November 16, 2006; 355(20): 2071 - 2084. [Abstract] [Full Text] [PDF]

				R. N. Foley Do We Know the Correct Hemoglobin Target for Anemic Patients with Chronic Kidney Disease? Clin. J. Am. Soc. Nephrol., July 1, 2006; 1(4): 678 - 684. [Abstract] [Full Text] [PDF]

				T. L. Roberts, R. N. Foley, E. D. Weinhandl, D. T. Gilbertson, and A. J. Collins Anaemia and mortality in haemodialysis patients: interaction of propensity score for predicted anaemia and actual haemoglobin levels Nephrol. Dial. Transplant., June 1, 2006; 21(6): 1652 - 1662. [Abstract] [Full Text] [PDF]

				F. K. Port, R. L. Pisoni, J. Bommer, F. Locatelli, M. Jadoul, G. Eknoyan, K. Kurokawa, B. J. Canaud, M. P. Finley, and E. W. Young Improving Outcomes for Dialysis Patients in the International Dialysis Outcomes and Practice Patterns Study Clin. J. Am. Soc. Nephrol., March 1, 2006; 1(2): 246 - 255. [Abstract] [Full Text] [PDF]

				P. S. Parfrey, R. N. Foley, B. H. Wittreich, D. J. Sullivan, M. J. Zagari, D. Frei, and for the Canadian European Study Double-Blind Comparison of Full and Partial Anemia Correction in Incident Hemodialysis Patients without Symptomatic Heart Disease J. Am. Soc. Nephrol., July 1, 2005; 16(7): 2180 - 2189. [Abstract] [Full Text] [PDF]

				H. I. Feldman, M. Joffe, B. Robinson, J. Knauss, B. Cizman, W. Guo, E. Franklin-Becker, and G. Faich Administration of Parenteral Iron and Mortality among Hemodialysis Patients J. Am. Soc. Nephrol., June 1, 2004; 15(6): 1623 - 1632. [Abstract] [Full Text] [PDF]

				J. J. Snyder, R. N. Foley, D. T. Gilbertson, E. F. Vonesh, and A. J. Collins Hemoglobin Levels and Erythropoietin Doses in Hemodialysis and Peritoneal Dialysis Patients in the United States J. Am. Soc. Nephrol., January 1, 2004; 15(1): 174 - 179. [Abstract] [Full Text] [PDF]

				I. C. Macdougall CREATE: new strategies for early anaemia management in renal insufficiency Nephrol. Dial. Transplant., June 1, 2003; 18(suppl_2): ii13 - ii16. [Abstract] [Full Text] [PDF]

				D. N. Reddan, D. L. Frankenfield, P. S. Klassen, J. A. Coladonato, L. Szczech, C. A. Johnson, A. Besarab, M. Rocco, W. McClellan, J. Wish, et al. Regional variability in anaemia management and haemoglobin in the US Nephrol. Dial. Transplant., January 1, 2003; 18(1): 147 - 152. [Abstract] [Full Text] [PDF]

				M. S. Joy and G. R. Matzke Introduction: Therapeutic Advances in Chronic Kidney Disease Journal of Pharmacy Practice, December 1, 2002; 15(6): 435 - 436. [PDF]

				J. A. Coladonato, D. L. Frankenfield, D. N. Reddan, P. S. Klassen, L. A. Szczech, C. A. Johnson, and W. F. Owen Jr. Trends in Anemia Management among US Hemodialysis Patients J. Am. Soc. Nephrol., May 1, 2002; 13(5): 1288 - 1295. [Abstract] [Full Text] [PDF]

				S. Oserman, S. Watnick, T. F. Griffith, J. A. Coladonato, W. F. Owen, Jr, J. A. Vassalotti, R. Manfredini, B. Boari, O. la Cecilia, F. Portaluppi, et al. Does Time of Day of Hemodialysis Affect Survival? JAMA, March 13, 2002; 287(10): 1262 - 1264. [Full Text] [PDF]

				E. O'Riordan and R. N. Foley When should we start erythropoietin therapy? Nephrol. Dial. Transplant., May 1, 2001; 16(5): 891 - 892. [Full Text] [PDF]

				R. J. MIDDLETON, P. S. PARFREY, and R. N. FOLEY Left Ventricular Hypertrophy in the Renal Patient J. Am. Soc. Nephrol., May 1, 2001; 12(5): 1079 - 1084. [Full Text]

				L. T. Goodnough, B. Skikne, and C. Brugnara Erythropoietin, iron, and erythropoiesis Blood, August 1, 2000; 96(3): 823 - 833. [Abstract] [Full Text] [PDF]

				C. Burton, D. Ansell, H. Taylor, E. Dunn, and T. Feest Management of anaemia in United Kingdom renal units: a report from the UK Renal Registry Nephrol. Dial. Transplant., July 1, 2000; 15(7): 1022 - 1028. [Abstract] [Full Text] [PDF]

				F. K. Port, R. A. Wolfe, P. J. Held, S. J. Bander, J. M. Lazarus, S. M. Lindenfeld, A. R. Nissenson, W. F. Owen, W. Y. Qunibi, D. J. Riley, et al. Ownership of Dialysis Facilities and Patients' Survival N. Engl. J. Med., April 6, 2000; 342(14): 1053 - 1056. [Full Text]

				H. XIA, J. EBBEN, J. Z. MA, and A. J. COLLINS Hematocrit Levels and Hospitalization Risks in Hemodialysis Patients J. Am. Soc. Nephrol., June 1, 1999; 10(6): 1309 - 1316. [Abstract] [Full Text]

				J. Z. MA, J. EBBEN, H. XIA, and A. J. COLLINS Hematocrit Level and Associated Mortality in Hemodialysis Patients J. Am. Soc. Nephrol., March 1, 1999; 10(3): 610 - 619. [Abstract] [Full Text]

				R. A. WARD and M. E. BRIER Retrospective Analyses of Large Medical Databases: What Do They TellUs? J. Am. Soc. Nephrol., February 1, 1999; 10(2): 429 - 432. [Full Text]

				O. Ifudu Care of Patients Undergoing Hemodialysis N. Engl. J. Med., October 8, 1998; 339(15): 1054 - 1062. [Full Text] [PDF]

Copyright © 2009 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673